Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06747364 · ClinicalTrials.gov registry record · NA

Phosphatidylethanol and Other Ethanol Consumption Markers

A NA study of Healthy Volunteer and Alcohol Consumption, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06747364: Recruiting NA study of Healthy Volunteer and Alcohol Consumption, sponsored by The University of Texas Health Science Center at San Antonio.

NCT06747364 is a NA study of Healthy Volunteer and Alcohol Consumption that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 80 participants, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06747364, a NA study of Healthy Volunteer and Alcohol Consumption, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

This study is intended to help the investigators understand how a biomarker found in the blood may be used to better identify the quantity and different patterns of alcohol use. The investigators hope that the results of this study will help identify the uses of alcohol-use markers in the blood in future alcohol prevention and treatment programs. It is hoped that the information learned from this study will benefit other people in the future. The study participants will come into the lab and will (1) consume alcohol in the lab designed to produce a peak blood alcohol concentration of 0.06% and have blood collected over 6 hours followed by abstinence for 10 days to give a small blood sample 4 times and (2) to give a small amount of blood 5 times within 28 days (naturalistic drinking) and provide answers about alcohol use.

Primary Outcome

Measure of PEth level in ng/ml over 360 minutes

Interventions

  • OTHER Alcohol (Ethanol)

Study Locations (2)

Texas

  • University of North Texas - Denton
  • University of Texas Health Science Center San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-01-07
Est. Completion 2029-06
Phase NA

What NCT06747364 shows while recruiting

NCT06747364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (60% lower).

The record links to 2 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which Alcohol (Ethanol) is the first listed.

NCT06747364 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06747364 about?

NCT06747364 is a clinical study titled "Phosphatidylethanol and Other Ethanol Consumption Markers". This study is intended to help the investigators understand how a biomarker found in the blood may be used to better identify the quantity and different patterns of alcohol use. The investigators hope that the results of this study will help identify the uses of alcohol-use markers in the blood in ...

What is the current status of trial NCT06747364?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-01-07. Estimated completion is 2029-06.

What conditions does trial NCT06747364 study?

This clinical trial studies the following conditions: Healthy Volunteer, Alcohol Consumption.

What interventions are being tested in trial NCT06747364?

The interventions under investigation include: Alcohol (Ethanol) (OTHER).

Who is sponsoring clinical trial NCT06747364?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06747364 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06747364's enrollment target sits among peer trials

80 41st of 112 higher than 70 of 112 other Healthy Volunteer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06747364, the US trial registry maintained by the National Library of Medicine. NCT06747364 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.